<rss version="2.0">
<channel>
<title>MindBranch: Medical</title>
<description>Medical market research products provide analysis of the latest trends, developments and market data for this industry.  Research information will help you make informed business decisions.</description>
<link>http://www.mindbranch.com/catalog/find.jsp?cat=md</link>
<item>
<title>Freedonia Focus on Medical &amp; Dental Adhesives &amp; Sealants</title>
<link>http://www.mindbranch.com/products/R761-1074.html</link>
<description> <![CDATA[This report discusses US demand for medical and dental adhesives and sealants for the years 2003 and 2008, with forecasts for 2013.  Topics covered include market size, product and market segmentation, material research and product development, regulatory considerations, market environment, product and market forecasts, industry composition and leading participants.  Product segments covered are medical adhesives and sealants (including internal medical and external medical), and dental adhesives and sealants (including professional dental and denture adhesives and sealants).  Markets covered are primary care, dental office and consumer.  This 20 page report also includes a highlights summary and a resources ]]></description>
<pubDate>Mon, 30 Nov 2009 00:00:00 EST</pubDate>
</item>
<item>
<title>Optometrists and Opticians</title>
<link>http://www.mindbranch.com/products/R3470-3278.html</link>
<description> <![CDATA[The retail optical industry in the US includes about 14,000 optician stores with combined annual revenue of $7 billion, and 16,000 offices of optometrists with combined annual revenue of $6 billion. Large opticians include Luxottica Retail (LensCrafters and Pearle Vision), Eye Care Centers of America, and US Vision. The optician segment of the market is fairly concentrated: the 50 largest chains hold about 60 percent of the market. The optometrist segment is highly fragmented.  Optometrists work mainly as solo practitioners or in small group practices. A typical group practice has less than $500,000 in annual revenue and four employees. About 1,000 practices have annual revenue over $1 million. Many optometrist practices include retail sales.   COMPETITIVE LANDSCAPE  Demand is driven by demographics, fashion, and changing healthcare practices. Most important is the aging US population, which is increasing demand for eye exams and glasses. The profitability of optometrist practices depends on efficient operations and ]]></description>
<pubDate>Mon, 16 Nov 2009 00:00:00 EST</pubDate>
</item>
<item>
<title>Global Digital Economy - E-Government, E-Health and E-Education Trends</title>
<link>http://www.mindbranch.com/products/R170-1258.html</link>
<description> <![CDATA[This annual report offers a wealth of information on the worldwide development of digital economy in terms of e-government, e-health and e-education. It offers analyses, statistics, forecasts and key trends. It provides insight into National Broadband Network (NBN) infrastructure developments and strategy. Regional information on developments in North America, Latin America, Europe, Middle East, Africa and Asia Pacific are also provided, where applicable. 
  Subjects covered include:  
 Key elements of the digital economy; 
 Global e-government overview and statistics; 
 Global e-health overview and statistics; 
 Global e-education overview; 
 Vision of the digital economy after the crisis; 
 Insight into National Broadband Network (NBN) developments; 
 Brief regional overviews on e-government, e-health and e-education developments where applicable. 
]]></description>
<pubDate>Wed, 11 Nov 2009 00:00:00 EST</pubDate>
</item>
<item>
<title>Testing Laboratories</title>
<link>http://www.mindbranch.com/products/R3470-3259.html</link>
<description> <![CDATA[The US testing laboratories industry includes about 4,800 companies with combined annual revenue of about $9 billion. Major companies include National Technical Systems, Wyle Laboratories, Underwriters Laboratories, and the US operations of Bureau Veritas and SGS. The industry is fragmented: the top 50 companies account for about 35 percent of industry revenue.  Testing labs provide a variety of engineering, quality control, and certification services by performing physical and chemical tests on products and processes. Companies perform these tests either in a lab or at the customer&rsquo;s site. The industry doesn't include medical or pharmaceutical testing.  COMPETITIVE LANDSCAPE  Demand is driven largely by industry and government spending on R&D to improve the efficiency of operations and develop new products and services. The profitability of individual companies depends on technical expertise and the ability to accurately predict project costs. Large labs have advantages in providing a larger breadth of service through multiple locations; some have ]]></description>
<pubDate>Mon, 09 Nov 2009 00:00:00 EST</pubDate>
</item>
<item>
<title>Profiting From Consumer Mega-Trends in Asia Pacific: Health</title>
<link>http://www.mindbranch.com/products/R313-57629.html</link>
<description> <![CDATA[ Introduction   For three-quarters of Asia Pacific consumers,  maintaining or improving health  has become more important to them personally over the last two years.     This report outlines how over 40 health-driven trends influence consumer lifestyles and product choices and considers the implications and opportunities for industry players   Scope   Detailed analysis outlining what constitutes 'value' for Asia Pacific consumers (trends are, after all, a reflection of what's important to consumers)  Offers Asia Pacific sector insights, benchmarked against global sentiment, to cater for contextualized regional specific information needs  Covers all major FMCG sectors, but also with applicability to wider consumer goods audiences  Part of Datamonitor's mega-trend report series which outline the most important issues shaping current and future buying behavior   Highlights   Good trend-watching is about taking the bigger-picture approach. Adopting a broader perspective to trend-tracking facilitates better decision making by overcoming 'category myopia'. Monitoring the broader FMCG environment will enable bigger picture learning that can be applied ]]></description>
<pubDate>Mon, 09 Nov 2009 00:00:00 EST</pubDate>
</item>
<item>
<title>Chiropractor Offices</title>
<link>http://www.mindbranch.com/products/R3470-3241.html</link>
<description> <![CDATA[The US chiropractic industry includes about 36,000 businesses and 60,000 licensed chiropractors with combined annual revenue of nearly $10 billion. No major companies dominate. The industry is highly fragmented: the top 50 chiropractor offices generate less than 10 percent of revenue.   COMPETITIVE LANDSCAPE  Demand for chiropractic services is driven by the aging US population and the overall acceptance of alternative medicine and chiropractic care. The profitability of individual companies depends on effective marketing and maximizing billable hours. Large companies have advantages in regional name recognition. Small companies can compete effectively by serving a small community or integrating the practice into a larger holistic health practice. The industry is labor-intensive: annual revenue per worker is about $80,000.   Chiropractors compete with physical therapists and medical doctors, many of whom consider chiropractic treatments ineffective.   PRODUCTS, OPERATIONS & TECHNOLOGY  A chiropractor's major service is treating patients who have pain due to muscular or skeletal injuries. Patient ]]></description>
<pubDate>Mon, 09 Nov 2009 00:00:00 EST</pubDate>
</item>
<item>
<title>Power Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015</title>
<link>http://www.mindbranch.com/products/R49-472.html</link>
<description> <![CDATA[LEXINGTON, Massachusetts (November 11, 2009) - WinterGreen Research announces that it has a new study on power wheelchairs. The 2009 study has 400 pages, 235 tables and figures. Worldwide markets are poised to achieve significant growth as the wheelchairs are used globally. Growth comes as the population ages in every region while the older people seek to maintain a mobile, independent lifestyle.   According to Susan Eustis, the lead author of the study, &ldquo;the purchase of power wheelchairs is dependent on reimbursement. The use of power wheelchairs is based on providing a chair that has appeal to those who does not have the ability to walk one quarter mile. The inability to walk distances is impossible for some people, yet they resist getting a wheel chair. Custom units, light weight units, stable chairs, comfortable chairs are all an issue in general market as baby boomers reach retirement age and have the ]]></description>
<pubDate>Sat, 07 Nov 2009 00:00:00 EST</pubDate>
</item>
<item>
<title>The Future of the Diabetes Care Devices Market to 2015</title>
<link>http://www.mindbranch.com/products/R3480-14505.html</link>
<description> <![CDATA[The Future of the Diabetes Care Devices Market to 2015   Summary   Global Markets Direct&rsquo;s &ldquo;The Future of the Diabetes Care Devices Market to 2015&rdquo; report provides key data, information and analysis on the global diabetes care devices market. The report provides market landscape, competitive landscape and market trends information on the glucose monitoring and insulin delivery market categories. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report reviews the competitive landscape in terms of mergers and acquisitions, pipeline products and technology offerings.   Scope   The report covers data and analysis on the diabetes care devices market, a key segment within the medical device/medical equipment industry.  Data is provided for the leading geographies of the world comprising of the United States (US), Canada, United Kingdom (UK), Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.  The report covers global market size and company share ]]></description>
<pubDate>Wed, 04 Nov 2009 00:00:00 EST</pubDate>
</item>
<item>
<title>The Future of the Diagnostic Imaging Market to 2015</title>
<link>http://www.mindbranch.com/products/R3480-14506.html</link>
<description> <![CDATA[The Future of the Diagnostic Imaging Market to 2015   Summary   Global Markets Direct&rsquo;s &ldquo;The Future of the Diagnostic Imaging Market to 2015&rdquo; report provides key data, information and analysis on the global diagnostic imaging market. The report provides market landscape, competitive landscape and market trends information on six market categories including computed tomography systems, mammography equipment, MRI systems, nuclear imaging equipment, ultrasound systems and x-ray systems. This report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape in terms of mergers and acquisitions, pipeline products and technology offerings.   Scope   The report covers data and analysis on the diagnostic imaging market, a leading segment of the medical device/medical equipment industry  Data is provided for the leading geographies of the world - the US, Canada, UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.  The report covers global market size ]]></description>
<pubDate>Wed, 04 Nov 2009 00:00:00 EST</pubDate>
</item>
<item>
<title>Australia - The National Broadband Network</title>
<link>http://www.mindbranch.com/products/R170-1255.html</link>
<description> <![CDATA[This annual report offers a wealth of information on the trends and developments taking place in the e-government, e-health and e-education sectors. The report provides analyses of the issues surrounding the growth of such services and includes global and regional information. Comprehensive information on the exciting developments taking place on a regional level is also included.
  Subjects covered include: 
 The importance of broadband infrastructure; 
 Key issues and strategies needed for countries to develop their digital economies; 
 E-government market overview, analyses and statistics; 
 E-health market overview, analyses and statistics; 
 E-education market overview, analyses and ]]></description>
<pubDate>Wed, 04 Nov 2009 00:00:00 EST</pubDate>
</item>
<item>
<title>Weight Reduction Services</title>
<link>http://www.mindbranch.com/products/R3470-3233.html</link>
<description> <![CDATA[The US weight reduction services industry includes about 1,300 companies with combined annual revenue of almost $2 billion. Major companies include Weight Watchers, Nestl&eacute;'s Jenny Craig, NutriSystem, and the online-only eDiets. The industry is highly concentrated: the 50 largest companies account for 80 percent of industry revenue and the four largest, for 60 percent.  The industry doesn't include companies that provide primarily medical or surgical weight reduction, or those that operate physical fitness facilities, health resorts, or spas.  COMPETITIVE LANDSCAPE  Consumers' excess weight, personal income, and leisure time drive demand. The profitability of individual companies depends on effective marketing, customer acquisition and retention, and efficient operations. Large companies have advantages of scale in marketing, infrastructure, and partnerships. Small companies can compete effectively by offering individualized services or upscale facilities. The industry is labor-intensive: average annual revenue per worker is under $50,000.   PRODUCTS, OPERATIONS & TECHNOLOGY  Major product lines are program fees, food supplements, and ]]></description>
<pubDate>Mon, 02 Nov 2009 00:00:00 EST</pubDate>
</item>
<item>
<title>Medical Imaging Markets: Contrast Agents</title>
<link>http://www.mindbranch.com/products/R566-512.html</link>
<description> <![CDATA[The application and versatility of medical imaging modalities are continuing to grow in significance as the population ages and healthcare costs rise. Examinations that can facilitate earlier disease diagnosis and the most appropriate treatment are in order. This bodes well for contrast media markets.  
	Since our last round-up of the contrast media market, the economic environment in the world has changed.  Although the recession may have caused hospitals, physician offices and other institutions to delay or cancel the purchase of imaging equipment, it has not had a significant negative impact on the use of contrast agents with the equipment already on hand. Specifically, annual growth for medical contrast media during the next five years appears to be strong, despite the recession slowing capital equipment purchases. Imaging exams are still needed for many diagnoses, and contrast enhancement facilitates diagnosis in many cases. Kalorama expects growth ranges to remain ]]></description>
<pubDate>Sun, 01 Nov 2009 00:00:00 EST</pubDate>
</item>
<item>
<title>Infectious Disease Testing Market: US, Europe, Japan--Emerging Opportunities and Business Strategies</title>
<link>http://www.mindbranch.com/products/R3447-83.html</link>
<description> <![CDATA[The infectious disease testing market is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers in the 21st century.  Among the main driving forces behind the growth of this dynamic market is continuous spread of AIDS, which remains the world's major health threat and a major factor contributing to the rise in incidence of opportunistic infections; bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.  Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.  This comprehensive worldwide survey is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding ]]></description>
<pubDate>Sun, 01 Nov 2009 00:00:00 EST</pubDate>
</item>
<item>
<title>Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads</title>
<link>http://www.mindbranch.com/products/R566-514.html</link>
<description> <![CDATA[As Kalorama Information's lead diagnostic analyst finds, the point of care concept is at a crossroads: the technologies needed to make rapid testing a reality have arrived.   But is healthcare ready?     Kalorama believes that the drive for wellness and the attention surrounding healthcare reform will focus attention on rapid diagnostics. However, according to Shara Rosen, RT, M.B.A., there are many challenges which must be overcome for point of care solutions to be fully utilized, and those companies willing to pivot strategies and best adjust to tomorrow&rsquo;s healthcare marketplace may be rewarded.  
 
This report,  Point of Care Diagnostics 2010: Rapid Testing at a Crossroads  represents the most current analysis of the role POC Diagnostics in today's in vitro industry. Other reports have looked at products, companies and revenue numbers, as this report does. But in her analysis Shara Rosen takes a bold look into ]]></description>
<pubDate>Sun, 01 Nov 2009 00:00:00 EST</pubDate>
</item>
<item>
<title>Animal Health Report</title>
<link>http://www.mindbranch.com/products/R3468-11436.html</link>
<description> <![CDATA[The Global Animal Health Industry Report Plimsoll Publishing Ltd.  Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt?  This report is an in-depth financial evaluation of the Global Animal Health Industry. Using the unique Plimsoll method of analysis, each of the top 250 Animal Health Companies is individually assessed and ranked against each other and compared to industry averages. Using the most up-to-date financial information available, the two-page analysis provides detailed financial analysis for each organisation, including details of;    Sales growth    Trading stability   Profitability    Employee performance   Level of debt   Gearing ratio&rsquo;s   Creditor Exposure   Performance ratio&rsquo;s   Overall financial rating  Results are shown in graphical, numeric and narrative forms, and all individual analysis are measured in both the company&rsquo;s own currency, and USD ($) for ease of use. These individual analyses highlight a company&rsquo;s success just as easily ]]></description>
<pubDate>Sun, 01 Nov 2009 00:00:00 EST</pubDate>
</item>
<item>
<title>BI for Drug Development: Oracle Introduces Clinical Development Analytics</title>
<link>http://www.mindbranch.com/products/R104-40433.html</link>
<description> <![CDATA[ This IDC Health Insights Perspective highlights the announcement of a dedicated life science business intelligence (BI) solution introduced recently at Oracle OpenWorld 2009 that promises to deliver actionable insights into clinical development processes. Oracle Clinical Development Analytics (CDA) is a new product offering expected to be released by Oracle early next year. Built on Oracle's BI Enterprise Edition Plus platform, this new solution should provide near-real-time insights across the entire clinical development process, encompassing both current and previously completed trials. This information will be invaluable to all stakeholders involved and should help to make the overall drug development process more transparent. As highlighted in other IDC Health Insights research, we believe that the adoption of BI will be strong across the health industry ecosystem, driven by both financial and business pressures impacting the industry today.  This Perspective provides insights developed from a formal presentation and subsequent discussions with Dr. James Streeter, ]]></description>
<pubDate>Sun, 01 Nov 2009 00:00:00 EST</pubDate>
</item>
<item>
<title>Cooper Companies Medical Device Company Intelligence Report</title>
<link>http://www.mindbranch.com/products/R16-23330.html</link>
<description> <![CDATA[Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available.
]]></description>
<pubDate>Sat, 31 Oct 2009 00:00:00 EST</pubDate>
</item>
<item>
<title>Boston Scientific Medical Device Company Intelligence Report</title>
<link>http://www.mindbranch.com/products/R16-23329.html</link>
<description> <![CDATA[Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available.
]]></description>
<pubDate>Sat, 31 Oct 2009 00:00:00 EST</pubDate>
</item>
<item>
<title>Abbott Medical Device Company Intelligence Report</title>
<link>http://www.mindbranch.com/products/R16-23328.html</link>
<description> <![CDATA[Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available.
]]></description>
<pubDate>Sat, 31 Oct 2009 00:00:00 EST</pubDate>
</item>
<item>
<title>Invacare Medical Device Company Intelligence Report</title>
<link>http://www.mindbranch.com/products/R16-23331.html</link>
<description> <![CDATA[Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available.
]]></description>
<pubDate>Sat, 31 Oct 2009 00:00:00 EST</pubDate>
</item>
</channel>
</rss>
